Suchergebnisse - "Hou, Yixuan J"

PubPharm (53)

31

Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individuals

enthalten in: medRxiv : the preprint server for health sciences | 2021

von Markmann, A. | Giallourou, N. | Bhowmik, D. | +21

UpdateIn: mSphere. 2021 Aug 25;6(4):e0027521. - PMID 34431693

32

Chimeric Porcine Deltacoronaviruses with Sparrow Coronavirus Spike Protein or the Receptor-Binding Domain Infect Pigs but Lose Virulence and Intestinal Tropism

enthalten in: Viruses | 2021

von Niu, X. | Hou, Y. | Jung, K. | +3

33

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma

enthalten in: bioRxiv : the preprint server for biology | 2020

von Voss, W. | Hou, Y. | Johnson, N. | +32

UpdateIn: Science. 2021 May 4;:. - PMID 33947773

34

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

enthalten in: Science (New York, N.Y.) | 2020

von Hou, Y. | Chiba, S. | Halfmann, P. | +23

UpdateOf: bioRxiv. 2020 Sep 29;:. - PMID 33024969

35

Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid

enthalten in: Molecular cell | 2020

von Iserman, C. | Roden, C. | Boerneke, M. | +14

36

A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures

enthalten in: bioRxiv.org | 2020

von Dinnon, K. | Leist, S. | Schäfer, A. | +16

37

SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo

enthalten in: bioRxiv.org | 2020

von Hou, Y. | Chiba, S. | Halfmann, P. | +17

38

De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2

enthalten in: Science (New York, N.Y.) | 2020

von Linsky, T. | Vergara, R. | Codina, N. | +32

UpdateOf: bioRxiv. 2020 Aug 03;:. - PMID 32793910

39

A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice

enthalten in: Cell | 2020

von Leist, S. | Dinnon, K. | Schäfer, A. | +16

40

A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures

enthalten in: Nature | 2020

von Dinnon, K. | Leist, S. | Schäfer, A. | +16

UpdateOf: bioRxiv. 2020 May 07;:. - PMID 32511406